<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Previous studies have indicated that <z:chebi fb="0" ids="30351">2,2'-dipyridyl</z:chebi>, a <z:chebi fb="23" ids="18059">lipid</z:chebi>-soluble ferrous iron <z:chebi fb="0" ids="38161">chelator</z:chebi>, can reduce brain injury after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and reduce <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> after <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we examined the efficacy of <z:chebi fb="0" ids="30351">2,2'-dipyridyl</z:chebi> after <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e>) in 12-month-old mice </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> was modeled by intrastriatal injection of collagenase or autologous whole blood </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="30351">2,2'-Dipyridyl</z:chebi> or vehicle was administered intraperitoneally 2h before <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> (pretreatment) or 6h after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> (post-treatment) and then once daily for up to 3 days </plain></SENT>
<SENT sid="4" pm="."><plain>Mice in the pretreatment group were sacrificed 1 or 3 days after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> and examined for <z:mpath ids='MPATH_41'>iron deposition</z:mpath>, neuronal <z:hpo ids='HP_0011420'>death</z:hpo>, <z:mp ids='MP_0003674'>oxidative stress</z:mp>, microglial/astrocyte activation, neutrophil infiltration, and white matter damage </plain></SENT>
<SENT sid="5" pm="."><plain>Mice in the post-treatment group were examined for brain lesion volume and <z:hpo ids='HP_0000969'>edema</z:hpo> on day 3 and for neurologic deficits on days 1, 3, and 28 after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Pretreatment with <z:chebi fb="0" ids="30351">2,2'-dipyridyl</z:chebi> decreased iron accumulation and neuronal <z:hpo ids='HP_0011420'>death</z:hpo>, attenuated production of reactive oxygen species, reduced microglial activation without affecting astrocytes or neutrophil infiltration, and attenuated white matter damage </plain></SENT>
<SENT sid="7" pm="."><plain>Post-treatment reduced brain lesion volume and <z:hpo ids='HP_0000969'>edema</z:hpo> and improved neurologic function </plain></SENT>
<SENT sid="8" pm="."><plain>These results indicate that the <z:chebi fb="23" ids="18059">lipid</z:chebi>-soluble ferrous iron <z:chebi fb="0" ids="38161">chelator</z:chebi> <z:chebi fb="0" ids="30351">2,2'-dipyridyl</z:chebi> can reduce brain injury and improve functional outcome after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> </plain></SENT>
</text></document>